Search clinical trials for: Human EPO

Total 28007 results

Fundació Institut de Recerca de l'Hospital de la...
Palo Biofarma, S.L

Completed

"First-in-human" Study To Assess the Safety and Tolerability of PBF-680 in Male Healthy Volunteers

Asthma

Spain
Hoffmann-La Roche

Completed

A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.

Anemia

France
Bioven Europe

Terminated

A Randomized Trial to Study the Safety and Efficacy of EGF Cancer Vaccination in Late-stage (IIIB/IV) Non-small Cell Lung Cancer Patients (NSCLC)

Carcinoma, Non-Small-Cell Lung

United Kingdom
University Hospital, Angers

Completed

Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C

Chronic Hepatitis C

France
Universitaire Ziekenhuizen KU Leuven

Completed

Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL)

Reperfusion Injury

Belgium
Claudia Sue Robertson
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury

Anemia | Traumatic Brain Injury

United States
Nutrasource Pharmaceutical and Nutraceutical Services...
University of Guelph; Biodroga Inc.

Completed

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Cardiovascular Disease

Canada
Zhengzhou Children's Hospital, China
Zhengzhou University

Completed

Effect of Erythropoietin on Preterm Brain Injury (EPO)

Premature Birth

China
Centre Hospitalier Universitaire de Nice

Completed

Human Immunodeficiency Virus (HIV)and Chronic Obstructive Pulmonary Disease (COPD) (HIV and COPD)

Chronic Obstructive Pulmonary Disease

France
University of Copenhagen
Rigshospitalet, Denmark

Completed

Renal Effects of Erythropoietin in Humans (EPO 2012)

Renal Effects

Denmark
Celgene Corporation

Completed

A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic Syndromes

Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)

United States
Yonsei University

Completed

Prevention of Acute Kidney Injury by Erythropoietin in Thoracic Aorta Surgery With Hypothermic Cardiac Arrest

Dissection of Thoracic Aorta

Korea, Republic of
Johnson & Johnson Pharmaceutical Research & Development...

Withdrawn

A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies

Anemia
Vanderbilt University
National Institutes of Health (NIH)

Completed

The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans

Hypertension

United States
University of Zurich

Unknown

Non-erythroid Effects of Erythropoietin on Cognitive Function and Exercise Capacity in Humans

Healthy

Switzerland
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Patients With Pure Red Cell Aplasia Associated With Recombinant Human Erythropoietin Treatment

Pure Red-cell Aplasia

United Kingdom, Sweden, South Africa, Brazil, Canada, Germany, Norway, Thailand
Tel-Aviv Sourasky Medical Center

Unknown

Studying Erythropoietin Receptor Presence and Function in Human Cancer Specimens (EPO-CAN)

Cancer

Israel
Weill Medical College of Cornell University
Schering-Plough

Terminated

Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin

HIV Infections | Anemia | Neutropenia | Hepatitis C Virus

United States
Janssen-Cilag B.V.

Completed

Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)

Neoplasms | Anemia
University of Aarhus

Completed

Identification of New Serum Markers for Detection of Abuse With Erythropoietin

Substance Abuse Problem

Denmark
University of South Florida
Centers for Disease Control and Prevention

Completed

Human Safety of Capsaicin Inhalation Challenge Testing for Young and Older Men (Capsaicin)

COPD

United States
Rigshospitalet, Denmark

Unknown

Can Erythropoietin Protect the Cerebral Blood Flow and Oxygenation During Simulated Dive?

Healthy

Denmark
Dr. Conrado Fernandez

Completed

High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (DARGEN-3)

Chronic Hepatitis C

Spain
yair levy

Unknown

Autoantibodies Against Human Recombinant Erythropoietin in Myelodysplatic Syndrome Patients (MDS)

Myelodysplatic Syndrome

Israel
Stem Cell Therapeutics Corp.

Terminated

Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (REGENESIS-LED)

Stroke

Canada, India, United States
Epic Research & Diagnostics, Inc.

Completed

Prognostic Indicators as Provided by the EPIC ClearView (GBMC)

Coronary Artery Disease | Pneumonia | Hypertension | Diabetes | Irritable Bowel Syndrome | Atrial Fibrillation | Asthma | Renal Failure | Emphysema | Cholecystitis | Cirrhosis | Crohn's Disease | Ulcerative Colitis | Acute Renal Failure | Diverticulitis | Pancreatitis | Bronchitis | Valvular Heart Disease | Inflammatory Bowel Disease and other conditions

United States
Ain Shams University

Completed

Enteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial

Necrotizing Enterocolitis | Feeding Intolerance
Stem Cell Therapeutics Corp.

Withdrawn

REGENESIS (US): A Phase IIb Prospective, Randomized, Double-blind, Placebo Controlled Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (REGENESIS)

Stroke

United States
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Terminated

Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts

Myelodysplastic Syndromes

Italy
Hospital Authority, Hong Kong
The Hong Kong Society of Nephrology

Completed

A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients

Cardiovascular Diseases | Kidney Diseases | Chronic Disease

China
Ortho Biotech Products, L.P.

Completed

A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT)

Anemia | Chronic Renal Insufficiency
Ortho Biotech Products, L.P.

Completed

Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia

Anemia | Chemotherapy
Ortho Biotech Products, L.P.

Terminated

A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.

Anemia | Chronic Renal Insufficiency
University of Calgary
Stem Cell Therapeutics Corp.

Unknown

Safety Study of Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Traumatic Brain Injury: Dosing Tier 1

Traumatic Brain Injury

Canada
AstraZeneca

Completed

A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD

Chronic Obstructive Pulmonary Disease

United States, Peru, South Africa, Argentina, Mexico, Brazil, Chile, Colombia, Venezuela
Wageningen University
National Heart, Lung, and Blood Institute (NHLBI); Unilever R&D; Netherlands...

Completed

Alpha Omega Trial: Study of Omega-3 Fatty Acids and Coronary Mortality

Cardiovascular Diseases

Netherlands
Tanta University

Completed

Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE)

Hypoxic Ischemic Encephalopathy

Egypt
Stem Cell Therapeutics Corp.

Terminated

REGENESIS (CA): A Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (REGENESIS)

Stroke

Canada, India
University Hospital, Geneva

Completed

Recombinant Human Erythropoietin Use in Intensive Care Unit (ICU) Patients: Does it Prevent Acute Renal Failure

Acute Renal Failure

Switzerland
Cadila Pharnmaceuticals

Completed

Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure

Anemia

India
China Medical University Hospital

Unknown

Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants

Retinopathy of Prematurity | Intraventricular Hemorrhage | Infant, Premature | Leukomalacia, Periventricular

Taiwan
Aarhus University Hospital

Completed

Insulin Resistance and Substrate Metabolism After Acute Erythropoietin (EPO) Administration

Insulin Sensitivity

Denmark
Seoul National University Bundang Hospital

Completed

The Effect of Erythropoietin at the Time of Reperfusion in Acute Myocardial Infarction

Acute Myocardial Infarction

Korea, Republic of
Chugai Pharmaceutical

Completed

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Chemotherapy Induced Anemia
Chugai Pharmaceutical

Completed

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Chemotherapy Induced Anemia
Hospital Carlos III, Madrid

Unknown

Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients (PERICO)

Chronic Hepatitis C

Spain
Zhengzhou University
Göteborg University; Medical University Innsbruck; Zhengzhou Children's Hospital...

Completed

Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy

Hypoxic-Ischemic Encephalopathy

China
Max-Planck-Institute of Experimental Medicine
Johnson & Johnson; Parexel

Completed

Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke (ESS)

Infarction, Middle Cerebral Artery | Stroke, Acute | Middle Cerebral Artery Stroke

Germany
Amgen

Completed

Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis

Kidney Disease
Labbafinejhad Hospital
Shahid Beheshti University of Medical Sciences

Unknown

The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group

Transplantation, Kidney

3

Subscribe